Random X Inactivation and Extensive Mosaicism in Human Placenta Revealed by Analysis of Allele-Specific Gene Expression along the X Chromosome by Moreira de Mello, Joana Carvalho et al.
Random X Inactivation and Extensive Mosaicism in
Human Placenta Revealed by Analysis of Allele-Specific
Gene Expression along the X Chromosome
Joana Carvalho Moreira de Mello
1,E ´rica Sara Souza de Arau ´jo
1, Raquel Stabellini
1, Ana Maria Fraga
1,
Jorge Estefano Santana de Souza
2, Denilce R. Sumita
3, Anamaria A. Camargo
2, Lygia V. Pereira
1*
1Laborato ´rio de Gene ´tica Molecular do Departamento de Gene ´tica e Biologia Evolutiva, Universidade de Sa ˜o Paulo, Sa ˜o Paulo, Brazil, 2Sa ˜o Paulo Branch, Ludwig Institute
for Cancer Research, Sa ˜o Paulo, Brazil, 3Genomic Engenharia Molecular, Sa ˜o Paulo, Brazil
Abstract
Imprinted inactivation of the paternal X chromosome in marsupials is the primordial mechanism of dosage compensation
for X-linked genes between females and males in Therians. In Eutherian mammals, X chromosome inactivation (XCI) evolved
into a random process in cells from the embryo proper, where either the maternal or paternal X can be inactivated.
However, species like mouse and bovine maintained imprinted XCI exclusively in extraembryonic tissues. The existence of
imprinted XCI in humans remains controversial, with studies based on the analyses of only one or two X-linked genes in
different extraembryonic tissues. Here we readdress this issue in human term placenta by performing a robust analysis of
allele-specific expression of 22 X-linked genes, including XIST, using 27 SNPs in transcribed regions. We show that XCI is
random in human placenta, and that this organ is arranged in relatively large patches of cells with either maternal or
paternal inactive X. In addition, this analysis indicated heterogeneous maintenance of gene silencing along the inactive X,
which combined with the extensive mosaicism found in placenta, can explain the lack of agreement among previous
studies. Our results illustrate the differences of XCI mechanism between humans and mice, and highlight the importance of
addressing the issue of imprinted XCI in other species in order to understand the evolution of dosage compensation in
placental mammals.
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Introduction
In mammals, dosage compensation of X-linked gene products
between XX females and XY males is achieved by the
transcriptional inactivation of all but one X chromosome per
diploid cell in females early in embryogenesis. In marsupials, X
chromosome inactivation (XCI) is imprinted, and the paternal X is
inactivated in the embryo [1,2]. Imprinted XCI is also found in
Eutherians like mice, rats [3–5] and, although less extensively
characterized, bovines [6], however exclusively in extraembryonic
tissues. In cells of the embryo proper, either the paternal or the
maternal X chromosome is inactivated in a random fashion.
Traditionally, the process of XCI has been best studied in the
mouse, where it has been shown to be triggered by expression in cis
of the noncoding Xist gene exclusively from the future inactive X
(Xi), and to occur in two waves in the female pre-implantation
embryo (reviewed in [7]). Imprinted XCI becomes evident as early
as in the 4-cell stage [8–10], where expression of Xist exclusively
from the paternal X (Xp) results in its inactivation. At the
blastocyst stage, cells from the epiblast reactivate the paternal Xi ,
and then go through a second round of XCI, this time randomly
choosing the paternal or the maternal X as the inactive one [9,11].
Studies of XCI in human extraembryonic tissues date back to
late 1970 s, when the most common X-linked marker used was
glucose-6-phosphate dehydrogenase (G6PD) with its electropho-
retic variant isoforms (Table 1). The analysis of G6PD in samples
from term placentas provided conflicting results regarding the
pattern of XCI in those tissues, where both random [12] and
preferential inactivation [13–15] were reported. Contradicting
conclusions were also obtained in studies analyzing other
polymorphic X-linked loci in chorionic villi at different gestational
ages (Table 1) [16–20].
Some factors may account for these controversies, including
analysis of different tissues, small sample size and possible
contamination with maternal DNA. Additionally, it is important
to note that all those reports have relied on the analysis of only one
or two X-linked loci in order to infer the activity of the entire
chromosome (Table 1). However, some data indicate a possible
variability in the expression status of some genes from the Xi
among females [21,22], and therefore, the analysis of a single locus
may not be adequate to represent the expression activity of the
whole X chromosome.
Here we take advantage of the vast number of human X-linked
SNPs described [22,23] to perform for the first time an analysis of
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XCI in Human Placenta
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e10947allele-specific gene expression along the X chromosome in full-term
placenta. Our data indicate a heterogeneous maintenance of the
inactive state of genes on the Xi in that organ, confirming the
importance of analyzing several X-linked loci in order to infer the
pattern of XCI. Moreover, they show that the term placenta is
composed of relatively large clonal populations with either the
paternal or the maternalXi, which could be interpreted as completely
skewed XCI, and may explain the contradictory nature of the
previous reports. As a consequence, we conclude that XCI is random
in human placenta.
Results
Samples were collected from the fetal portion of 22 full-term
human placentas, and from the respective maternal oral mucosa
cells. Each placenta sample was tested for maternal DNA
contamination and to confirm maternal identity by PCR
amplification of 17 microsatellites in different autosomes and the
amelogenin locus (data not shown). In only one case (pl.05) the
maternal DNA sample did not match with the placental specimen
(data not shown), and therefore that maternal DNA was removed
from the analysis.
We selected 27 SNPs in exons of 22 X-linked genes expressed in
placenta whose transcriptional activity from the Xi had been
previously analyzed in non-randomly inactivated primary human
fibroblasts [22] (Figure 1, Table S1). Placental samples were
genotyped for these X-linked SNPs, resulting in at least 5
informative SNPs per sample (average of 9 informative SNPs/
sample). In addition, each SNP was informative in at least 4
samples (average of 10 informative samples/SNP) (Figure 1).
To evaluate allele-specific gene expression, cDNA of RNAs
from informative samples were genotyped by direct sequencing of
the respective RT-PCR products. As a control we used a cell line
of human fibroblasts with completely skewed XCI [24,25], in
which we were able to show monoallelic expression of 8
informative genes, including XIST, and biallelic expression of the
escapee gene ZFX in accordance with the expression profile of the
Xi [22] (Figure 2A).
We applied this analysis to the collection of placental specimens,
determining the origin of the expressed allele for each informative
gene (Figure 1, Figure 2B–D). In contrast with results from the
fibroblast cell line, where a clear mono or biallelic expression
pattern was observed for each gene analyzed, many placental
samples showed intermediate allelic ratios (Figure 2D) that were
quantified with the PeakPicker software [26]. For each gene, DNA
from heterozygous and homozygous samples were used to set up
the threshold values of expected allelic ratios corresponding to
random (50:50) and completely skewed XCI (0:100), respectively.
Figure 3 shows representative examples of the PeakPicker analysis
per gene and per sample. For the escapee gene ZFX, this analysis
placed most samples in or close to the 50:50 ratio of expressed
alleles, reflecting its biallelic expression pattern (Figure 3A). In
contrast, TCEAL4 and GPC4, genes subjected to XCI, displayed a
wider variability of allelic ratios among different samples, ranging
from 0:100 to 50:50 (Figure 3B–C). Values of allelic ratios from
experimental replicas fell within the same range, showing the
robustness of the quantification method (Figure 3D). PeakPicker
results were obtained for those electropherograms with phred
scores greater than 20 (16 SNPs in 15 genes) (Figure S1, Figure
S2). The remaining 11 SNPs were classified by visual analysis of
the electropherograms (Figure 1).
Figure 1 summarizes our data after quantification. The ratios of
expressed alleles observed in each locus were used to classify
samples in three categories regarding the XCI pattern: completely
Figure 1. Summary of allele-specific X-linked gene expression in human placenta. Ratios of expressed alleles for each locus are shown: red
(0:100); pink (between 0:100 and 20:80); green (above 20:80). Ratios of expressed alleles were scored by PeakPicker or visual analysis (*) of
electropherograms. GM135, completed skewed XCI human fibroblast cell line. Placental samples (pl.) are grouped as showing predominantly
completely skewed, skewed, or random inactivation. (ND) not determined. (-) non-informative locus; (X) informative locus; (M) expression from
maternal allele; (P) expression from paternal allele. Column one: gene symbol; Column two: chromosomal position as in Vega Human View, v35 - Mar
2009 (http://vega.sanger.ac.uk/Homo_sapiens/index.html). Column three: SNP variant according to NCBI dbSNP BUILD129 (http://www.ncbi.nlm.nih.
gov/SNP/). Column four: Gene expression on the Xi, where expression results are indicated as the number of primary human fibroblasts expressing
each gene from the Xi per number fibroblasts tested, or (1) number of rodent/human somatic cell hybrids with the Xi that expressed the gene per
number of hybrids tested [22].
doi:10.1371/journal.pone.0010947.g001
XCI in Human Placenta
PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10947Figure 2. Analyses of expressed alleles in human term placenta. Examples of electropherograms of DNA and cDNA sequences of X-linked
SNPs in (A) completely skewed fibroblast GM135; (B) pl.19; (C) pl.28; and (D) pl.17. Genes symbols and corresponding SNP ID are indicated above.
Sequences from DNA and cDNA from cell line/placental samples, and corresponding maternal (mat.) DNA are shown. SNP position is highlighted in
yellow. In (A) ZFX is shown as an example of a gene that escapes XCI.
doi:10.1371/journal.pone.0010947.g002
Figure 3. Quantification of ratio of expressed alleles using PeakPicker software. Solid lines indicate threshold levels for 0:100 (lower) and
50:50 (upper) ratios of expressed alleles. Dotted line indicates theoretical ratio of 20:80. Open circles represent data from genomic DNA, filled circles
from cDNA (filled triangles are experimental replicas), and asterisks from cDNA of completely skewed fibroblast GM135. Gene symbols and
corresponding SNP ID are indicated. Analysis of (A) ZFX (escapes XCI), (B) TCEAL4 and (C) GPC4 (subjected to XCI) genes in different placentas; (D)
Ratios of expressed alleles of different genes in pl.05 – threshold levels and theoretical ratio of 20:80 is shown for each gene.
doi:10.1371/journal.pone.0010947.g003
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e10947skewed (allelic ratios at or below the 0:100 threshold), skewed
(allelic ratios between 0:100 and 20:80), and random (allelic ratios
at or above 20:80). We found consistency regarding the parental
origin of the highest expressed allele within all samples classified as
skewed or completely skewed, allowing us to score 9 samples as
presenting preferential paternal XCI (pl.01, pl.02, pl.06, pl.07,
pl.08, pl.10, pl.11, pl.19, and pl.27), and 3 with preferential
inactivation of the maternal X (pl.21, pl.28, and pl.30). In
addition, 5 of these 12 samples showed consistent opposite
parental origin of the expressed XIST allele when compared to
the other X-linked genes (Figure 1: pl.08, pl.11, pl.19, pl.21 and
pl.28; Figure 2B, 2C). Five additional placental samples (Figure 1:
pl.17, pl.18, pl.22, pl.24 and pl.25) presented patterns consistent
with random XCI. A puzzling pattern was observed in pl.03,
where two loci showed completely skewed pattern of inactivation,
while two other loci presented random inactivation (Figure 1).
To reconcile the variable patterns observed, we proposed that
XCI is in fact random in placenta, which is organized in patches of
cells with either the maternal or the paternal inactive X, as
previously observed by analysis of the AR locus [27]. To test this
hypothesis with more X-linked genes, we collected 3 additional
placentas and analyzed allele-specific gene expression in three
different non-adjacent fragments of each (Figure 4). While allele-
specific gene expression analysis of XIST and OPHN1 in fragment
(a) from placenta 31 indicated random XCI pattern, fragments (b)
and (c) from the same placenta showed skewed and completely
skewed XCI, respectively (Figure 4A). Similar results were
observed for XIST and PIGA genes in placenta 32, and TSPAN7
and VBP1 in placenta 33 (Figure 4B, 4C). Together, these data
corroborate our hypothesis and demonstrate that each isolated
fragment from a single placenta may yield different results
regarding patterns of XCI.
Discussion
Imprinted inactivation of the paternal X chromosome occurs in
marsupials as the ancestral mechanism of dosage compensation
between the genders in Therians (reviewed in [7]). During the 147
million years that separate Metatheria from Eutheria [28], this
process acquired an additional pathway exclusively in the epiblast
cells, consisting of reactivation of the Xi and a second round of
XCI, this time random, as observed in mice [9,11]. The question
Figure 4. Mosaicism of the human full-term placenta regarding XCI. Electropherograms of DNA and cDNA sequences of X-linked SNPs in
three different fragments of placentas (A) 31, (B) 32 and (C) 33. Gene symbols and corresponding SNP ID are indicated. SNPs are highlighted in yellow.
doi:10.1371/journal.pone.0010947.g004
XCI in Human Placenta
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e10947remains: how much more has XCI evolved from that mammal to
humans?
XCI in human embryos has been recently shown to be present
as early as at the 8-cell stage [29], indicating that pre-implantation
XCI has been evolutionary conserved between humans and mice.
However, it has not been determined whether at that stage
inactivation was imprinted or random. Although imprinted XCI
in humans has been the subject of several studies for the last 30
years, a careful analysis of published results and their conclusions
reveals that this issue is still controversial (reviewed in [7,29]). Even
the two most recent articles on this subject have reported random
and non-random inactivation in different extraembryonic tissues
[20,30]. Since all those studies relied on data from only one or two
X-linked loci (Table 1), we set forth to readdress this issue in
human term placenta, performing a more robust analysis of allele-
specific gene expression along the X chromosome. This allowed us
to conclude that XCI is random in that organ.
The analysis of multiple X-linked loci in each sample revealed
that the expression behavior of the chromosome as a whole may
not be inferred from that of a single locus. For instance, analysis of
TIMP1 alone would indicate skewed and random XCI in
placentas pl.11 and pl.30, respectively (Figure 1). However,
considering the data from the other informative loci, those
samples are better classified as presenting completely skewed
XCI. In fact, although the data on allele-specific expression was
consistent within each sample in terms of parental origin of the
highest expressed allele, in most samples the allelic ratios varied
among different loci (Figure 1), suggesting a heterogeneous
relaxation of the epigenetic state along the Xi in this organ.
Indeed, Xi chromosomes from term placenta have been shown to
be more amenable to reactivation in human/rodent somatic cell
hybrids than those from other somatic tissues [31,32]. Our data in
the in vivo system is compatible with the reactivation of some genes
on the Xi, and thus corroborate those observations in vitro.I ti s
interesting to notice that such extensive variation was not observed
in the GM135 cell line, nor in a panel of 30 primary human
fibroblasts [22], which indicates that maintenance of XCI may
indeed be less stringent in placenta. A similar analysis in different
human tissues will be important to show whether the relaxation of
XCI is restricted to extraembryonic tissues, or it is a more general
feature of this epigenetic control. In summary, our data show that
the expression behavior of the Xi in human placenta can be
heterogeneous, and justify the analysis of multiple loci in order to
infer the pattern of XCI. Thus, we argue that a similar multi-loci
approach should be employed in order to confirm imprinted XCI
in bovine placenta, which has been determined by the analysis of a
single X-linked gene [6].
Finally, the analysis of a considerable number of samples
allowed us to identify diverse patterns of XCI only consistent with
random inactivation in the placenta, and the arrangement of this
organ in patches of cells as large as 8 mm
3 (see Materials and
Methods) with the same Xi. The analysis of different non-adjacent
fragments of the same specimen confirmed this mosaicism, and is
in accordance with results obtained independently for the AR and
the FMR1 genes in term placenta and chorionic villi, respectively
[27,33]. Actually, if one considered the extensive mosaicism of
those tissues, most of the data in the literature would be in
agreement with random XCI in the human extraembryonic
lineage, although some of the authors do not conclude that
(Table 1). The only two studies that identified exclusively non-
random XCI had important limitations: the first one relied on data
from only two samples [18]; while the second was performed in
trophoblast cells derived from the H9 line of human embryonic
stem cells [30], which has recently been shown to present
instability of the epigenetic state of the X chromosome [34,35],
and may not be modeling human XCI adequately in vitro.
Most of the currently known molecular mechanisms involved in
XCI are conserved between humans and mice (reviewed in [7]).
However, there are fundamental differences in that process
between the two species, including the structure of the TSIX/
Tsix gene (reviewed in [36]), and lack of imprinted XCI in
extraembryonic tissues as thoroughly characterized here. It is
interesting to notice that several autosomal genes imprinted
exclusively in the murine placenta are not under this epigenetic
control in humans [37]. Since the epigenetic marks of imprinted
autosomes and of the imprinted Xi are similar in mouse placenta
(reviewed in [38,39]), one may envision that imprinted XCI in
human extraembryonic tissues was lost during evolution in
conjunction with autosomal imprinting. Nevertheless, it is
noteworthy the preponderance of placental samples with prefer-
ential expression of maternal alleles, indicating that, although
imprinted XCI was lost during evolution, a proliferative advantage
may remain for cells that inactivate the Xp in human placenta. In
light of our data, it will be important to address the issue of
imprinted XCI in other Eutherians in order to understand the
evolution of dosage compensation in placental mammals.
Materials and Methods
Samples
Twenty two human full-term placentas with corresponding
maternal oral mucosa samples were collected at Amparo Maternal
Obstetric Clinic (Sa ˜o Paulo, Brazil), with parental fully informed
consent and approval by the local Institutional Ethics Committee.
Only placentas resulting from normal pregnancies and delivery of
a healthy female child were included in this study. Placental
fragments were collected from the fetal portion near the umbilical
cord insertion, washed several times in PBS to remove traces of
maternal blood, and rapidly submerged in RNA stabilizing
solution (RNAlater
TM QIAGEN) (samples 1–30). For placentas
numbered 31, 32 and 33, three fragments were obtained from
distinct nonadjacent regions of the same placenta and individually
processed in a similar way. Maternal oral mucosa samples were
stabilized in 50 mM NaOH.
Nucleic acid extraction
Maternal genomic DNA was extracted as described [40].
Placental genomic DNA was extracted from 25 mg fragments,
previously digested with 360 mL of lysis buffer (Amersham
Biosciences, GE) and 40 mL of proteinase K (20 mg/mL) at
55uC over night, using GFX
TM Genomic Blood DNA Purification
Kit according to manufacturer’s protocol (Amersham Biosciences,
GE).
Total RNA was prepared from up to 100 mg (4–8 mm
3
fragments) of placental tissue using TrizolHReagent (Invitrogen)
according to manufacturer’s protocol, previous digested with
20 mg/ml proteinase K for 30 minutes at 55uC. To avoid DNA
contamination, rigorous DNase treatment with Turbo DNA-Free
(Ambion) was performed, following manufacturer’s instructions.
One to 2 mg of total DNase-treated RNA were reverse transcribed
using M-MLV (Invitrogen) according to manufacturer’s protocol.
To test for DNA contamination, cDNA synthesis was also
performed in the absence of reverse transcriptase (minus-RT
control).
SNP selection and primers design
Based on the human X chromosome sequence [23], NCBI
dbSNP BUILD 129 (http://www.ncbi.nlm.nih.gov/SNP), and the
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fibroblasts [22], we selected 27 SNPs located in coding regions of
22 X-linked genes expressed in placenta. All primers were
designed avoiding annealing in known SNPs regions. The list of
SNPs and primers is presented in Table S1.
Genotyping and analysis of allele-specific expression
Fifty to 100 ng of DNA or cDNA were used as templates for
PCR amplification of the region surrounding each SNP with the
primers listed in Table S1. PCR conditions are available on
request. Before sequencing, PCR products were separated in 6%
poliacrilamyde gel electrophoresis, and visualized by silver staining
to exclude assays showing any amplification from the minus-RT
control reaction and from the minus-template PCR control.
Sequencing was carried out using those same primers and the
BigDyeH Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems). Sequencing products were separated on an ABI
PrismH 3100 Genetic Analyzer, following manufacturer’s instruc-
tions (Applied Biosystems). Most samples were analyzed at least
twice for each SNP, including distinct cDNA synthesis, RT-PCRs
and sequencing assays.
Quantification of allele-specific gene expression
Allelic expression levels were determined using the PeakPicker
software specifically developed for relative quantification of peaks in
sequencing electropherograms [26]. Because peak heights vary
depending on sample, base type and their position within the
sequence, the PeakPicker software carries out a normalization step in
which the SNP allele height is compared to the height of reference
peaks in flanking sequence. Default normalization settings were
applied to quantify the relative amount of the two alleles measured
from the electropherogram based on peak intensity of the two
polymorphic bases. Subsets of informative heterozygotes, at least five
for each SNP, were identified and their cDNA was amplified in
identical conditions to verify the peak height ratio between bases
corresponding to the SNP. We limited our PeakPicker analysis to
sequence traces in which 70% of the bases within a 21 base window
flanking the SNP presented phred quality score .20 [41,42]. Ratio
values above 1 were transformed to 1/(ratio)to set allofthemin a0–1
scale and then adjusted to the mean of the peak intensity ratios from
DNA samples. Genomic DNA from heterozygous and homozygous
samples were used to set up a threshold for allelic ratios of 50:50 and
0:100, respectively, for each gene. The normalized heterozygote and
homozygote ratios of genomic DNA samples were then used to
estimate the methodological variability and establish a 99%
confidence interval (CI) for 50:50 and 0:100 ratios of expressed
alleles, respectively. The 99% CI was calculated assuming that
normalized peak height ratios of DNA samples are normally
distributed according to the Anderson-Darling test. In addition, a
theoretical threshold of 20:80 ratio was calculated for each gene by
dividing the respective interval between 50:50 and 0:100. The pattern
ofXCIforeach samplewasbasedontheanalysisofallelicratiosof all
informative loci. Allelic ratios above 20:80 were indicative of random
XCI [43]; between 20:80 and 0:100 were considered as skewed XCI;
and only those ratios at or below 0:100 were classified as completely
skewed XCI.
Supporting Information
Table S1 Genes analyzed and respective PCR primers used.
Found at: doi:10.1371/journal.pone.0010947.s001 (0.03 MB
XLS)
Figure S1 Quantification of ratio of expressed alleles per gene
using PeakPicker software. Solid lines indicate threshold levels for
0:100 (lower) and 50:50 (upper) ratios of expressed alleles. Dotted
line indicates theoretical ratio of 20:80. Open circles represent
data from genomic DNA, filled circles from cDNA (filled triangles
are experimental replicas), and asterisks from cDNA of completely
skewed fibroblast GM135. Gene symbols and corresponding SNP
ID are indicated.
Found at: doi:10.1371/journal.pone.0010947.s002 (2.26 MB TIF)
Figure S2 Quantification of ratio of expressed alleles per sample
using PeakPicker software. PeakPicker results for all informative
SNPs in each placental (pl.) sample are shown. For each gene, solid
line indicates threshold levels for 0:100 ratio of expressed alleles,
and dotted line indicates theoretical ratio of 20:80. Filled circles
represent data from cDNA. Gene symbols are indicated.
Found at: doi:10.1371/journal.pone.0010947.s003 (4.88 MB TIF)
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